Comparison of replicating and nonreplicating vaccines against SARS-CoV-2
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Comparison of replicating and nonreplicating vaccines against SARS-CoV-2
Authors
Keywords
-
Journal
Science Advances
Volume 8, Issue 34, Pages -
Publisher
American Association for the Advancement of Science (AAAS)
Online
2022-08-25
DOI
10.1126/sciadv.abm8563
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Current State of the First COVID-19 Vaccines
- (2021) Birgit M. Prüβ Vaccines
- Emerging SARS-CoV-2 variants reduce neutralization sensitivity to convalescent sera and monoclonal antibodies
- (2021) Jie Hu et al. Cellular & Molecular Immunology
- Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence
- (2021) Ester C Sabino et al. LANCET
- Successful treatment of Thrombotic thrombocytopenia with cerebral sinus venous thrombosis following Ad26. COV2 .S vaccination
- (2021) Gemlyn George et al. AMERICAN JOURNAL OF HEMATOLOGY
- US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021
- (2021) Isaac See et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination
- (2021) Kate-Lynn Muir et al. NEW ENGLAND JOURNAL OF MEDICINE
- Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination — Response from the Manufacturer
- (2021) Jerald Sadoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Thrombocytopenia and splanchnic thrombosis after Ad26. COV2 .S vaccination successfully treated with transjugular intrahepatic portosystemic shunting and thrombectomy
- (2021) Roshni Dhoot et al. AMERICAN JOURNAL OF HEMATOLOGY
- Vaccine‐induced thrombotic thrombocytopenia following Ad26.COV2.S vaccine in a man presenting as acute venous thromboembolism
- (2021) Mouhamed Yazan Abou‐Ismail et al. AMERICAN JOURNAL OF HEMATOLOGY
- Immune-Mediated Thrombocytopenia Associated With Ad26.COV2.S (Janssen; Johnson & Johnson) Vaccine
- (2021) Sanchari Banerjee et al. AMERICAN JOURNAL OF THERAPEUTICS
- Transient Thrombocytopenia With Glycoprotein-Specific Platelet Autoantibodies After Ad26.COV2.S Vaccination: A Case Report
- (2021) Hanny Al-Samkari et al. ANNALS OF INTERNAL MEDICINE
- The Fc-mediated effector functions of a potent SARS-CoV-2 neutralizing antibody, SC31, isolated from an early convalescent COVID-19 patient, are essential for the optimal therapeutic efficacy of the antibody
- (2021) Conrad E. Z. Chan et al. PLoS One
- Early Outcomes of Bivalirudin Therapy for Thrombotic Thrombocytopenia and Cerebral Venous Sinus Thrombosis After Ad26.COV2.S Vaccination
- (2021) Richard Todd Clark et al. ANNALS OF EMERGENCY MEDICINE
- Fatal vaccine-induced immune thrombotic thrombocytopenia (VITT) post Ad26.COV2.S: first documented case outside US
- (2021) Elsa V. C. Rodriguez et al. INFECTION
- Vaccine-Induced Immune Thrombotic Thrombocytopenia with Concurrent Arterial and Venous Thrombi Following Ad26.COV2.S Vaccination
- (2021) Andreas Charidimou et al. Journal of Stroke & Cerebrovascular Diseases
- Understanding risk of thrombosis with thrombocytopenia syndrome after Ad26.COV2.S vaccination
- (2021) Prathit A. Kulkarni et al. Frontiers of Medicine
- ChAdOx1 interacts with CAR and PF4 with implications for thrombosis with thrombocytopenia syndrome
- (2021) Alexander T. Baker et al. Science Advances
- Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
- (2020) Pedro M Folegatti et al. LANCET
- Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques
- (2020) Noe B. Mercado et al. NATURE
- ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques
- (2020) Neeltje van Doremalen et al. NATURE
- A Replicating Single-Cycle Adenovirus Vaccine Effective against Clostridium difficile
- (2020) William E. Matchett et al. Vaccines
- OUP accepted manuscript
- (2018) JOURNAL OF INFECTIOUS DISEASES
- Pathology in Permissive Syrian Hamsters after Infection with Species C Human Adenovirus (HAdV-C) Is the Result of Virus Replication: HAdV-C6 Replicates More and Causes More Pathology than HAdV-C5
- (2017) Ann E. Tollefson et al. JOURNAL OF VIROLOGY
- HAdV-C6 Is a More Relevant Challenge Virus than HAdV-C5 for Testing Antiviral Drugs with the Immunosuppressed Syrian Hamster Model
- (2017) et al. Viruses-Basel
- Transgene Expression and Host Cell Responses to Replication-Defective, Single-Cycle, and Replication-Competent Adenovirus Vectors
- (2017) Catherine Crosby et al. Genes
- Replicating Single-Cycle Adenovirus Vectors Generate Amplified Influenza Vaccine Responses
- (2016) Catherine M. Crosby et al. JOURNAL OF VIROLOGY
- Amplified and Persistent Immune Responses Generated by Single-Cycle Replicating Adenovirus Vaccines
- (2014) Catherine M. Crosby et al. JOURNAL OF VIROLOGY
- IIIa deleted adenovirus as a single-cycle genome replicating vector
- (2014) Catherine M. Crosby et al. VIROLOGY
- IL-33-Responsive Lineage-CD25+CD44hi Lymphoid Cells Mediate Innate Type 2 Immunity and Allergic Inflammation in the Lungs
- (2011) K. R. Bartemes et al. JOURNAL OF IMMUNOLOGY
- Identification of a broad coverage HLA-DR degenerate epitope pool derived from carcinoembryonic antigen
- (2009) Lavakumar Karyampudi et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Characterization of human adenovirus serotypes 5, 6, 11, and 35 as anticancer agents
- (2009) Elena V. Shashkova et al. VIROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now